The global AI in blood pressure monitoring market size was estimated at USD 932.52 million in 2024 and is projected to reach USD 4.38 billion by 2030, growing at a CAGR of 29.98% from 2025 to 2030. Rising prevalence of hypertension and cardiovascular diseases, increasing demand for continuous and non-invasive monitoring, and growing consumer adoption of smart health devices are significant factors contributing to market growth.
Furthermore,
advancements in AI & sensor technologies fuel market growth. Innovations in
machine learning, edge computing, and biosensor miniaturization have
significantly enhanced the accuracy and reliability of blood pressure
estimation. AI can identify patterns and anomalies across vast data sets,
allowing for personalized insights and predictive alerts, which improve user
engagement and clinical decision-making. AI-powered monitoring systems use
photoplethysmography (PPG) sensors to measure blood pressure, oxygen
saturation, etc. For instance, in August 2024, Bisam Pharmaceuticals
launched Quick Vitals, an AI and deep learning-powered health monitoring app in
Hyderabad, India. This app uses Photoplethysmography (PPG) technology for
rapid, accurate vital sign assessments such as heart rate, blood pressure,
SPO2, etc., via smartphones or tablets in seconds.
In
addition, the healthcare industry's adoption of AI-powered wearables is
expanding rapidly. AI enhances its utility by analyzing large volumes of
physiological data to detect anomalies, predict health risks, and enable timely
interventions. This improves patient outcomes and reduces the burden on
healthcare systems by minimizing hospital visits and enabling telehealth
services. For instance, in June 2024, Sky Labs launched CART BP, a smart
ring for continuous blood pressure monitoring. The ring provides real-time,
non-invasive blood pressure tracking using advanced sensors and AI algorithms.
Request a free sample copy
or view report summary: AI In Blood Pressure Monitoring Market Report
List of Key Players in the AI In Blood Pressure
Monitoring Market
- Withings
- Aktiia SA
- Biospectal
SA
- Valencell,
INC.
- Biofourmis
- Edwards
Lifesciences Corporation (now BD)
- Hello Heart
- FaceHeart
Corporation
- Shen AI
- Huawei
Technologies Co., Ltd.
Key Market
Trends & Insights
·
North America AI in blood pressure monitoring market accounted
for the largest revenue share of over 49% in 2024.
·
The U.S. AI in blood pressure monitoring market held the largest
market share in 2024.
·
By end use, the hospitals & acute care segment held the
largest market share of over 39% in 2024.
·
By application, the hypertension management segment accounted
for the largest revenue share of over 37% in 2024.
·
By technology, the machine learning segment accounted for the
largest revenue share of over 51% in 2024.
Recent Developments
- In May 2025, Hyderabad-based Niloufer Hospital launched
AmruthSwasthBharath, an AI-based diagnostic tool for non-invasive blood
testing. This device provides results in under a minute, utilizing Remote
Photoplethysmography (PPG) to measure key health parameters such as blood
pressure, heart rate, SpO2, respiration rate, and hemoglobin A1c via
smartphones.
- In April 2025, BD introduced the HemoSphere Alta platform, an
advanced hemodynamic monitoring solution featuring AI-driven algorithms.
This technology assists clinicians in managing blood pressure instability
and optimizing blood flow during critical situations. Key innovations
include the Cerebral Autoregulation Index and the Acumen Hypotension
Prediction Index, enhancing patient care and outcomes.
"HemoSphere Alta marks the
latest milestone in our continuum of connected care innovations by redefining
the clinician experience with more efficient workflows and increased usability.
These AI-driven enhancements of advanced algorithms and machine learning
provide clinicians with more insights and clinical decision support to help
improve the quality of care for their patients."
- Tim Patz, president of BD
Advanced Patient Monitoring
- In February 2025, Validic launched a generative AI-powered assistant
for remote patient monitoring (RPM) using generative AI (GenAI)
within its Validic Impact platform. Utilizing Generative AI, the solution
automatically analyzes variations in vital health metrics such as blood
glucose levels, blood pressure, medication adherence, and lifestyle
factors, delivering clinicians insights between patient evaluations.
- In June 2024, Wellth, a digital health startup, enhanced its app with
AI-driven, personalized, predictive features for blood pressure
management. The app analyzes user-submitted blood pressure photos,
provides tailored alerts, and incentivizes healthy behaviors.
- In July 2021, Zepp Health unveiled a new smartwatch OS that measures
blood pressure using its PumpBeats algorithm, powered by the Huangshan 2s
AI chip and biosensors.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
